Amgen
The Clinical Development Director will lead early phase clinical development of cardiometabolic and general medicine therapeutic candidates, overseeing protocol design, study start‑up, data review, monitoring and analysis from first‑in‑human through proof‑of‑concept. The role collaborates with cross‑functional teams and external experts to shape development strategies and support regulatory and partnership activities.
Headquarters
Thousand Oaks, California, United States
Company Size
10001+ employees
Founded
1980
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amgen.
42% above the average for this role
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained
1 day ago
Clinical Development Director, Early Development – Cardiometabolic/General
lifelancer
Clinical Development Director, Early Development – Inflammation/Rare Disease
lifelancer
Medical Director/Senior Medical Director, Clinical Development
Tenvie Therapeutics
Global Development Lead, Early Clinical Development, Internal Medicine
Pfizer
Director, Clinical Science
Pathos
Global Development Lead, Internal Medicine (MD, Sr. Director)
Pfizer